Description

Budesonide 0.5 mg Respules is an inhaled corticosteroid formulation designed for administration through a nebulizer. Budesonide helps reduce inflammation and swelling in the airways and is used as prescribed in the management of respiratory conditions associated with airway inflammation.

The respule format provides a convenient option for nebulization, particularly when inhalation through conventional inhalers may be difficult. It can be positioned within a respiratory-care portfolio for hospitals, clinics, pediatric care and respiratory specialists.

Key Benefits

• Contains Budesonide 0.5 mg for nebulization.
• Helps reduce inflammation in the airways.
• Suitable for use through a compatible nebulizer as directed.
• Convenient unit-dose respule presentation.
• Can be included in respiratory and pulmonary-care portfolios.
• Useful addition to a respiratory pharma franchise product range.

Composition

Each respule contains:

• Budesonide – 0.5 mg
• Sterile aqueous vehicle – q.s.

Indications / Uses

Budesonide nebulization may be prescribed for the management of inflammatory respiratory conditions such as:

• Asthma and airway inflammation
• Wheezing associated with airway inflammation
• Other respiratory conditions where inhaled corticosteroid therapy is prescribed

Use only under the direction of a qualified healthcare professional. The exact indication, dose and duration depend on the patient’s condition and medical assessment.

Dosage Form

Respules / Nebulizer Suspension

For inhalation through a suitable nebulizer, as directed by the physician.

Packaging

Available in convenient unit-dose respules, subject to the final marketed pack configuration.

Pharma Franchise Opportunity

Budesonide 0.5 mg Respules can be a valuable addition to a respiratory pharma franchise portfolio, particularly for businesses targeting pulmonologists, pediatricians, physicians, hospitals and clinics.

A respiratory-focused pharma franchise range can help distributors and PCD pharma partners build a dedicated portfolio covering inhalation and nebulization-based therapies.

Why Choose Budesonide 0.5 mg Respules?

• Established corticosteroid molecule for respiratory care
• Convenient nebulization format
• Suitable for inclusion in respiratory-care portfolios
• Addresses demand across clinical respiratory settings
• Potentially suitable for PCD pharma franchise and respiratory product portfolios